SCHEMBL2960328

SCHEMBL2960328

CCOC(=O)c1ccc(COc2ccc(C(=O)c3ccc(OCC(C)C)cc3O)cc2CCC(=O)O)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JUN P05412 3/20 0.59
FOS P01100 2/20 0.59
UGT1A1 P22309 1/20 0.48
UGT1A3 P35503 1/20 0.48
UGT1A8 Q9HAW9 1/20 0.48
PPARG P37231 8/20 0.43
PPARD Q03181 8/20 0.43
PPARA Q07869 6/20 0.43
MEN1 O00255 1/20 0.42
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.42
KMT2A Q03164 1/20 0.42
HSD17B10 Q99714 1/20 0.42
HPGD P15428 1/20 0.42
PTGER1 P34995 1/20 0.41
PTGER4 P35408 1/20 0.41
PTGER3 P43115 1/20 0.41
PTGER2 P43116 1/20 0.41
LTB4R Q15722 2/20 0.39
FFAR4 Q5NUL3 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2968375 0.91 JUN (0.61) JUNFOSUGT1A1UGT1A3UGT1A8
SCHEMBL4279563 0.87 JUN (0.76) JUNFOSUGT1A1UGT1A3UGT1A8
SCHEMBL2956891 0.84 JUN (0.67) JUNFOSUGT1A1UGT1A3UGT1A8
SCHEMBL2963557 0.84 JUN (0.47) JUNFOSUGT1A1UGT1A3UGT1A8
SCHEMBL2968731 0.82 JUN (0.70) JUNFOSUGT1A1UGT1A3UGT1A8
SCHEMBL4282160 0.81 JUN (0.66) JUNFOSUGT1A1UGT1A3UGT1A8
SCHEMBL4276620 0.81 JUN (0.81) JUNFOSUGT1A1UGT1A3UGT1A8
SCHEMBL2954291 0.80 JUN (0.50) JUNFOSUGT1A1UGT1A3UGT1A8
SCHEMBL4291386 0.80 JUN (0.52) JUNFOSUGT1A1UGT1A3UGT1A8
SCHEMBL2959153 0.79 JUN (0.54) JUNFOSUGT1A1UGT1A3UGT1A8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7772285-B2 Benzophenone derivatives or salts thereof TOYAMA CHEMICAL CO., LTD. (JP) 2010-08-10 US disclosed
US-20050113400-A1 Inhibitors of transcription factor AP-1; autoimmune diseases; rheumatoid arthritis; high safety and excellent pharmacokinetics in vivo SHUNICHI SHIOZAWA (JP) 2005-05-26 US disclosed
EP-1445249-A1 NOVEL BENSOPHENONE DERIVATIVES OR SALTS THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2004-08-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113400-A1 Inhibitors of transcription factor AP-1; autoimmune diseases; rheumatoid arthritis; high safety and excellent pharmacokinetics in vivo SP1, AP1G1, JUN JUN 3/4885FOS 163/4885UGT1A1 1244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.